-
Innovation Ranking
NewInnovation Ranking – China Tobacco International HK Co Ltd
China Tobacco International HK Co Ltd (CTIC) is a distributor of cigarettes and tobacco leaf products. The company offer products which include cigarettes, tobacco leaf products and heat-not-burn tobacco products. CTIC provides offshore platform for capital markets operation and international business expansion. The company markets its products through a network of distribution channel and duty-free outlets. It has operational presence in Thailand, Singapore, Hong Kong, Macau and Taiwan. CTIC is headquartered in Kowloon, Hong Kong.
-
Company Insights
Innovation and Patenting activity of HK inno.N Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of HK inno.N Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of China Tobacco International HK Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of China Tobacco International HK Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CJ-30072 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CJ-30072 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CJ-30072 in Type 2 Diabetes Drug Details: CJ-30072 is under development...
-
Analyst Opinions
NewLeisure and Hospitality Construction Project Insights and Analytics (Q1 2024)
Leisure and Hospitality Construction Projects Market Overview GlobalData is currently tracking leisure and hospitality building pipeline projects that are cumulatively valued at $1.85 trillion. The projects comprise hotels and resorts along with mixed-use developments that include a significant component of leisure and hospitality-related projects. Furthermore, North America accounts for the highest share of room additions during 2024-2028. The leisure and hospitality construction projects market research report offers a detailed analysis of leisure and hospitality construction projects globally. The report also...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CAR-T Cell in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CAR-T Cell in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CAR-T Cell in Acute Lymphocytic Leukemia...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ADG-116 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ADG-116 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ADG-116 in Solid Tumor Drug Details: ADG-116 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LNS-8801 in Neuroendocrine Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LNS-8801 in Neuroendocrine Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LNS-8801 in Neuroendocrine Cancer Drug Details: LNS-8801 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Neuroendocrine Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Neuroendocrine Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Neuroendocrine Carcinoma Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a...